Merck Animal Health has a proud history of improving the lives of animals and the people who care for them. Now our experience is helping us shape the future. So, while we cherish our beginnings, we also know we are more than a sum of our parts. Today we’re striving to become an even more ambitious, innovative force for progress in science. Our intestinal health platform is made up of market-leading vaccines offering protection against coccidiosis and internal parasites. Our leading range of vaccines for respiratory problems includes live virus vector vaccines, offering protection against Marek’s disease, Newcastle disease (ND), Infectious Bursal Disease and Infectious Laryngotracheitis (ILT). We always remember that the work we do is essential to the safety of global food production, and to human health. The supply of high-quality protein is at the heart of changing lifestyles across the world. We are committed to developing vital solutions including vaccines and medicines that poultry producers need to ensure disease prevention and sustainable, efficient production. | At Merck Animal Health, we are shaping the future of animal health with pioneering science, connected technology and insights-driven solutions to bring our customers an unparalleled portfolio of choices to improve cattle care and operational efficiency. We support you and your legacy by helping you meet the challenges of today with the innovations of tomorrow.
Maze Therapeutics
Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with kidney disease. The company is advancing a pipeline designed to translate insights from protective genetic variants into potential new therapies, led by investigational programs in APOL1-mediated kidney disease and chronic kidney disease.
Mayo Clinic Platform
Mayo Clinic Platform, a critical embodiment of Mayo Clinic’s Bold. Forward. vision to transform healthcare, brings together healthcare providers, pharmaceutical companies, medical device companies, health tech startups, patients, and payers to drive innovation and share knowledge, solutions, and technologies to improve patients’ lives.
Manta Cares
Manta Cares is a platform to support cancer patients and care partners, from diagnosis to survivorship. We provide clinically validated information, practical tools, and a community of support to help navigate the highs and lows of the cancer experience.
MannKind Corporation
MannKind focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with orphan lung and endocrine diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as IPF, PAH and NTM. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. | At MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. Our approach begins with our cutting-edge technology and is driven by solutions-based scientists and medical professionals who are dedicated to helping people experience the very best life has to offer. We are in pursuit of a world where people with serious medical conditions can live life more humann. | MannKind Corporation is a biopharmaceutical company dedicated to transforming chronic use disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.
Luye Pharma USA Ltd.
Luye Pharma (USA) Ltd. is a US-based pharmaceutical company dedicated to the research, development, manufacturing, and distribution of innovative medications. Luye Pharma (USA) Ltd. entered the US market in 2025 with a novel formulation of a long-acting injectable (LAI), and has a robust pipeline focused on CNS disorders. Luye Pharma (USA) Ltd. is committed to providing improved therapeutic options for healthcare professionals, helping make small changes that may make a big difference in the lives of patients and those around them. | Luye Pharma Group (part of Luye Life Sciences Group) is an international pharmaceutical company dedicated to the R&D, manufacturing, and sale of innovative medications. Luye is an emerging player in the US market with 2 FDA-approved products and a pipeline focusing on CNS Disorders.
LENZ Therapeutics
LENZ Therapeutics is pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia.